Dr. Sabine Steffens studied Biology at the Justus-Liebig-University in Giessen, Germany and received her PhD title from the Heinrich-Heine-University in Düsseldorf in December 2001. She discovered an interest for cardiovascular research during her postdoctoral time in Geneva, Switzerland (2003 – 2006). Her first groundbreaking discovery was on anti-inflammatory effects of plant cannabinoid in experimental atherosclerosis in 2005. Since 2013, she is Associate Professor for Clinical Pathobiochemistry at the Ludwig-Maximilians-University. Her research focuses on the role of the endocannabinoid system and related endogenous signalling pathways during inflammatory processes underlying atherosclerosis and cardiac repair. Recent breakthroughs where achieved by identifying an important role for neutrophils in post-myocardial infarction healing and the influence of the circadian rhythm on these processes.
